Sign In
Buy XBI
$129.83
+2.07 (+1.62%)
At Close: Jun 03, 2026
Here's Why Clinical-Stage Biotechs Get Hit Harder During a Market Decline
01:00pm, Sunday, 21'st Mar 2021
Short-term investors may not see the long-term potential.
Healthcare Dashboard For March And Focus On XBI
04:27pm, Thursday, 18'th Mar 2021
A dashboard with metrics in healthcare industries.
5 ETF Investing Areas for March to Boost Returns
04:40pm, Wednesday, 03'rd Mar 2021
Here we discuss a few ETFs that can enrich investors' portfolio in March amid a strong wave of optimism surrounding the coronavirus vaccine and introduction of another round of fiscal stimulus.
Stocks Off to a Solid Start in March: 6 Bargain ETF Picks
10:36am, Tuesday, 02'nd Mar 2021
Given the jump in investors' sentiment, ETFs that still trade at bargain price seem excellent pick.
Investing in Biotech is a Long Game: Schulman
09:03pm, Friday, 26'th Feb 2021
Feb.26 -- Polaris Partners Managing Partner Amy Schulman says that the key to investing in biotech is to diversify by investing in a portfolio. She cautions that biotech investments can be risky, but
Spiking Yields Pierce Bonds & Growth Stocks
08:46pm, Wednesday, 17'th Feb 2021
Interest rates hit their highest levels in a year on Wednesday, putting pressure on long-duration assets.
How Will Biotech ETFs React to These Q4 Earnings Releases?
03:54pm, Friday, 05'th Feb 2021
Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry post their fourth-quarter earnings releases amid the coronavirus crisis.
Biotech sector will continue to see activity: Margie Patel
03:02pm, Thursday, 04'th Feb 2021
Andy Kapyrin, Regent Atlantic director of research, and Margie Patel, Wells Fargo Asset Management senior portfolio manager and managing director, join CNBC's "The Exchange" to discuss the current inf
Best Biotech ETFs for Q2 2021
02:25pm, Wednesday, 03'rd Feb 2021
The best biotech ETFs for Q2 2021 are ARKG, IDNA, and XBI.
Short-Sellers Have These 3 ETFs in Their Sights
12:31am, Wednesday, 03'rd Feb 2021
Should investors watch for a squeeze?
Biotech ETFs extend January gains
10:39am, Monday, 01'st Feb 2021
Biotech exchange-traded funds rallied Monday as investors continued to monitor the sector and its impact on the coronavirus pandemic. The ETFMG Treatments Testing and Advancement ETF gained 4.6% mid-m
Why I'm Betting Big on This 1 Megatrend
06:01am, Monday, 25'th Jan 2021
It's a big bet but not a big gamble.
A Guide to Biotech ETF Investing Amid the Coronavirus Crisis
02:18pm, Tuesday, 12'th Jan 2021
The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.
ETF Areas Thriving During Coronavirus Pandemic
06:48pm, Thursday, 07'th Jan 2021
We highlight some ETF areas that held their ground and gained popularity among investors amid the coronavirus crisis.
XBI: Riding The Coming Biotech Buyout Bonanza With The SPDR Biotech ETF
11:21am, Tuesday, 05'th Jan 2021
The world is awash with liquidity as interest rates remain at historic lows. Cheap liquidity is the fuel that will spark the next buyout bing in smaller cap biotech.
